Opportunities Preloader

Please Wait.....

Report

Cell and Gene Therapy Manufacturing Services Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Market Report I 2024-08-02 I 114 Pages I Global Market Insights

Cell and gene therapy manufacturing services market size is set to record an 18.9% CAGR during 2024-2032 driven by rapid advancements in biotechnology and the increasing prevalence of genetic disorders and chronic diseases. As innovative therapies for conditions like cancer, genetic disorders, and rare diseases continue to emerge, there is a growing demand for specialized manufacturing services to produce high-quality, customized cell and gene therapies.
Pharmaceutical companies, biotech firms, and research institutions are increasingly outsourcing their manufacturing needs to specialized service providers to scale up production and ensure compliance with stringent regulatory standards. For instance, in April 2024, Memel Biotech introduced a comprehensive service for advanced therapy development and manufacturing. The complexity of cell and gene therapies also necessitates sophisticated manufacturing processes, which drives demand for expertise and infrastructure provided by dedicated service providers.
The overall industry is divided into type, mode, indication, end user, and region.
Based on type, the cell and gene therapy manufacturing services market from the gene therapy segment is expected to generate notable revenue by 2032. This is due to its innovative approach in treating genetic disorders and diseases at a molecular level. As gene therapy progresses with advanced techniques, such as CRISPR and viral vector-based methods, the need for specialized manufacturing services to produce these complex therapies has increased.
In terms of end user, the cell and gene therapy manufacturing services market value from the hospitals segment is projected to observe a robust CAGR from 2024 - 2032. This is owing to the increasing adoption of advanced therapies for patient treatment within hospital settings. As hospitals expand their capabilities to offer cutting-edge treatments for complex diseases, they rely on specialized manufacturing services to provide high-quality, customized cell and gene therapies.
Asia Pacific cell and gene therapy manufacturing services industry size will grow between 2024 and 2032 driven by the increasing prevalence of genetic and chronic diseases, coupled with significant advancements in biotechnology. The expanding healthcare infrastructure and growing investments in R and D activities are enhancing the capabilities for producing sophisticated cell and gene therapies. The supportive government policies and incentives aimed at fostering innovation and improving healthcare outcomes are also contributing to regional market expansion.

Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer and other diseases
3.2.1.2 Increasing government grants and support for development of cell and gene therapies
3.2.1.3 Increasing pharmaceutical R and D spending
3.2.2 Industry pitfalls and challenges
3.2.2.1 High risk of mutagenesis
3.2.2.2 Lack of standardized production systems for cell and gene therapy products
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Canada
3.4.3 Europe
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Thermo Fisher Scientific Inc.
4.1.2 Boehringer Ingelheim International GmbH
4.1.3 Merck KGaA
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Company matrix analysis
4.5 Vendor matrix analysis
4.6 Competitive positioning matrix
4.7 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)
5.1 Key trends
5.2 Cell therapy
5.2.1 Allogenic
5.2.1.1 Mesenchymal stem cells
5.2.1.2 T-cells
5.2.1.3 Natural killer cells
5.2.1.4 Hematopoietic stem cells
5.2.1.5 Other allogeneic cells
5.2.2 Autologous
5.2.2.1 Mesenchymal stem cells
5.2.2.2 T-cells
5.2.2.3 Natural killer cells
5.2.2.4 Hematopoietic stem cells
5.2.2.5 Other allogeneic cells
5.3 Gene therapy
5.3.1 Viral vectors
5.3.2 Non-viral vectors
Chapter 6 Market Estimates and Forecast, By Mode, 2018 - 2032 ($ Mn)
6.1 Key trends
6.2 Contract manufacturing
6.3 In-house manufacturing
Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)
7.1 Key trends
7.2 Oncology diseases
7.3 Cardiovascular diseases
7.4 Orthopedic diseases
7.5 Infectious diseases
7.6 Ophthalmology diseases
7.7 Other indications
Chapter 8 Market Estimates and Forecast, By End user, 2018 - 2032 ($ Mn)
8.1 Key trends
8.2 Biopharmaceutical companies
8.3 Academic research institutes
8.4 Hospitals
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.2 Bluebird Bio, Inc.
10.3 Catalent, Inc.
10.4 Charles River Laboratories International, Inc.
10.5 Merck KGaA
10.6 Miltenyi Bioindustry (Miltenyi Biotec)
10.7 Samsung Biologics
10.8 Takara Bio Inc.
10.9 Thermo Fisher Scientific Inc
10.10 WuXi AppTec Co., Ltd.

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE